Published on in CHOP News
$4 million gift from the Escoll-Lubeck Charitable Foundation will support innovative and high-quality care to children with feeding and swallowing disorders and their families.
Published on in GI Updates
Regional and local differences in the diagnosis and treatment of celiac disease affects outcomes for youth.
Published on in GI Updates
Two recent studies show dupilumab improves eosinophilic esophagitis symptoms and pathology for adolescents and young adults.
Published on in GI Updates
When rumination and gastroparesis collide in patients at Children’s Hospital of Philadelphia, a personalized treatment plan is developed.
Published on in GI Updates
Continued surveillance after pancreatic solid pseudopapillary tumor and pancreatic insufficiency is important – even after treatment.
Published on in GI Updates
Very early onset inflammatory bowel disease was virtually unheard of just a decade ago. Today, a variety of personalized therapies exist, and potential curative gene therapies are on the horizon.
Published on in CHOP News
Researchers from CHOP and Penn are working to perfect 3D models of GI disease and create more personalized treatments for patients.
Published on in CHOP News
CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.
Published on in GI Updates
When most people hear ‘Halloween,’ ‘candy’ tends to be a word that follows. But Halloween candy can be tricky for kids with celiac disease.
Published on in CHOP News
Get to know Dr. Joshua Eisenberg, our newest attending physician in the Division of Gastroenterology, Hepatology and Nutrition.